Junshi Biosciences to Seek H-Share Repurchase Mandate at 27 July 2026 EGM

Bulletin Express07-08 22:24

Shanghai Junshi Biosciences Co., Ltd. (Junshi Biosciences) has issued a notice for its 2026 first extraordinary general meeting (EGM), scheduled for 27 July 2026 at 2:50 p.m. on the 15th Floor, Building 7, No. 6, Lane 100, Pingjiaqiao Road, Pudong New Area, Shanghai.

The sole agenda item is a special resolution authorising a general mandate for the company to repurchase its H shares. Voting will be conducted by poll, with results to be released on the company’s website and Hong Kong Exchanges and Clearing’s information platform.

Key administrative arrangements:

• Share register closure: 22 – 27 July 2026 (both days inclusive). • Record date: 27 July 2026. • Deadline for lodging H-share transfer documents: 4:30 p.m., 21 July 2026, with Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong. • Proxy submission: H-shareholders must deposit completed forms with Tricor at least 24 hours before the meeting.

Shareholders may appoint one or more proxies, who need not be shareholders, to attend and vote on their behalf. The current board, chaired by Mr. Xiong Jun, comprises seven executive directors, two non-executive directors and six independent non-executive directors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1191400913?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-08 22:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1191400913","market":"us","top_or_hot":-1,"title":"Junshi Biosciences to Seek H-Share Repurchase Mandate at 27 July 2026 EGM","media":"Bulletin Express","content":"<p>Shanghai Junshi Biosciences Co., Ltd. (Junshi Biosciences) has issued a notice for its 2026 first extraordinary general meeting (EGM), scheduled for 27 July 2026 at 2:50 p.m. on the 15th Floor, Building 7, No. 6, Lane 100, Pingjiaqiao Road, Pudong New Area, Shanghai.</p>\n<p>The sole agenda item is a special resolution authorising a general mandate for the company to repurchase its H shares. Voting will be conducted by poll, with results to be released on the company’s website and Hong Kong Exchanges and Clearing’s information platform.</p>\n<p>Key administrative arrangements:</p>\n<p>• Share register closure: 22 – 27 July 2026 (both days inclusive).  \n• Record date: 27 July 2026.  \n• Deadline for lodging H-share transfer documents: 4:30 p.m., 21 July 2026, with Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.  \n• Proxy submission: H-shareholders must deposit completed forms with Tricor at least 24 hours before the meeting.</p>\n<p>Shareholders may appoint one or more proxies, who need not be shareholders, to attend and vote on their behalf. The current board, chaired by Mr. Xiong Jun, comprises seven executive directors, two non-executive directors and six independent non-executive directors.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Junshi Biosciences to Seek H-Share Repurchase Mandate at 27 July 2026 EGM</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJunshi Biosciences to Seek H-Share Repurchase Mandate at 27 July 2026 EGM\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-08 22:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Junshi Biosciences Co., Ltd. (Junshi Biosciences) has issued a notice for its 2026 first extraordinary general meeting (EGM), scheduled for 27 July 2026 at 2:50 p.m. on the 15th Floor, Building 7, No. 6, Lane 100, Pingjiaqiao Road, Pudong New Area, Shanghai.</p>\n<p>The sole agenda item is a special resolution authorising a general mandate for the company to repurchase its H shares. Voting will be conducted by poll, with results to be released on the company’s website and Hong Kong Exchanges and Clearing’s information platform.</p>\n<p>Key administrative arrangements:</p>\n<p>• Share register closure: 22 – 27 July 2026 (both days inclusive).  \n• Record date: 27 July 2026.  \n• Deadline for lodging H-share transfer documents: 4:30 p.m., 21 July 2026, with Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.  \n• Proxy submission: H-shareholders must deposit completed forms with Tricor at least 24 hours before the meeting.</p>\n<p>Shareholders may appoint one or more proxies, who need not be shareholders, to attend and vote on their behalf. The current board, chaired by Mr. Xiong Jun, comprises seven executive directors, two non-executive directors and six independent non-executive directors.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01877","symbol_name":"君实生物","start_time":0,"source_url":"","article_id":"1191400913","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1191400913","pubTimestamp":1783520665,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Junshi Biosciences Co., Ltd. (Junshi Biosciences) has issued a notice for its 2026 first extraordinary general meeting (EGM), scheduled for 27 July 2026 at 2:50 p.m. on the 15th Floor,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01877":"君实生物"},"translate_title":"君实生物将于2026年7月27日股东特别大会上寻求H股购回授权","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01877":1},"content_text":"Shanghai Junshi Biosciences Co., Ltd. (Junshi Biosciences) has issued a notice for its 2026 first extraordinary general meeting (EGM), scheduled for 27 July 2026 at 2:50 p.m. on the 15th Floor, Building 7, No. 6, Lane 100, Pingjiaqiao Road, Pudong New Area, Shanghai.\nThe sole agenda item is a special resolution authorising a general mandate for the company to repurchase its H shares. Voting will be conducted by poll, with results to be released on the company’s website and Hong Kong Exchanges and Clearing’s information platform.\nKey administrative arrangements:\n• Share register closure: 22 – 27 July 2026 (both days inclusive).  \n• Record date: 27 July 2026.  \n• Deadline for lodging H-share transfer documents: 4:30 p.m., 21 July 2026, with Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong.  \n• Proxy submission: H-shareholders must deposit completed forms with Tricor at least 24 hours before the meeting.\nShareholders may appoint one or more proxies, who need not be shareholders, to attend and vote on their behalf. The current board, chaired by Mr. Xiong Jun, comprises seven executive directors, two non-executive directors and six independent non-executive directors.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1191400913","isCrawlerRequest":true}